Domany K, Mandelberg A, Burrack N, Golan-Tripto I, Masarweh K, Gur M
Pediatr Pulmonol. 2025; 60(3):e71022.
PMID: 40042149
PMC: 11881211.
DOI: 10.1002/ppul.71022.
Maglione M, Tipo V, Barbieri E, Ragucci R, Ciccarelli A, Esposito C
J Clin Med. 2025; 14(4).
PMID: 40004915
PMC: 11856189.
DOI: 10.3390/jcm14041387.
Chen C, Chen Y, Hsiao H, Chang Y, Li H, Aydin M
Heliyon. 2025; 11(3):e42229.
PMID: 39995910
PMC: 11848077.
DOI: 10.1016/j.heliyon.2025.e42229.
Xu X, Chen X, He J, Su L, Tong X, Sun Y
Infect Drug Resist. 2025; 18:835-845.
PMID: 39963370
PMC: 11830755.
DOI: 10.2147/IDR.S496239.
Gantenberg J, van Aalst R, Diakun D, Bengtson A, Limone B, Nelson C
PLoS One. 2025; 20(2):e0313573.
PMID: 39928629
PMC: 11809781.
DOI: 10.1371/journal.pone.0313573.
Changes in infant respiratory pathogens pre-, during, and post-COVID-19 non-pharmacological interventions in Beijing.
Han T, Wang Y, Zhang D, Li Y, Zhang L, Yan J
Ital J Pediatr. 2025; 51(1):8.
PMID: 39844210
PMC: 11752787.
DOI: 10.1186/s13052-025-01848-5.
Respiratory Syncytial Virus: A WAidid Consensus Document on New Preventive Options.
Ricco M, Abu-Raya B, Icardi G, Spoulou V, Greenberg D, Pecurariu O
Vaccines (Basel). 2025; 12(12.
PMID: 39771979
PMC: 11679680.
DOI: 10.3390/vaccines12121317.
Exploring the epidemiological burden of RSV pre- and post-COVID-19 pandemic: A Jordanian tertiary hospital experience.
Al-Zayadneh E, Marie D, Khraisat F, Musa S, AlSamhori J, Altamimi D
J Int Med Res. 2024; 52(12):3000605241306405.
PMID: 39719069
PMC: 11683821.
DOI: 10.1177/03000605241306405.
Network pharmacology, molecular docking, and untargeted metabolomics reveal molecular mechanisms of multi-targets effects of Qingfei Tongluo Plaster improving respiratory syncytial virus pneumonia.
Yang M, Zhang X, Liu Q, Wang Y
Chin Herb Med. 2024; 16(4):638-655.
PMID: 39606255
PMC: 11589485.
DOI: 10.1016/j.chmed.2024.07.007.
Incidence and severity of community acquired pneumonias in children before and after the COVID-19 pandemic.
Koliou M, Aristidou A, Mazeri S, Nikolopoulos G, Argyrou M, Haralambous C
J Public Health (Oxf). 2024; 47(1):9-14.
PMID: 39580230
PMC: 11879108.
DOI: 10.1093/pubmed/fdae292.
Effects of nonpharmaceutical interventions during COVID-19 pandemic on pediatric asthma exacerbations and viral infections.
Caid K, Tate M, Yousuf S, Jones L, Pesek R, Jefferson A
J Allergy Clin Immunol Glob. 2024; 3(4):100340.
PMID: 39498233
PMC: 11533078.
DOI: 10.1016/j.jacig.2024.100340.
Respiratory Syncytial Virus Infections in Pediatric Intensive Care: Association of Sociodemographic Data and Clinical Outcomes with Viral and Bacterial Co-infections.
Kocoglu Barlas U, Akcay N, Telhan L, Kangin M, Umur O, Citak A
Turk Arch Pediatr. 2024; 59(5):494-500.
PMID: 39440440
PMC: 11391245.
DOI: 10.5152/TurkArchPediatr.2024.24149.
Epidemiologic trends and changes in humoral immunity and lymphocyte subsets levels among hospitalized children with Mycoplasma pneumoniae infection during 2019-2023.
Tang L, Zheng K, Ma L, Chen L, Zhao Y, Li L
Eur J Clin Microbiol Infect Dis. 2024; 43(9):1837-1845.
PMID: 39023633
DOI: 10.1007/s10096-024-04901-z.
Whole genome molecular analysis of respiratory syncytial virus pre and during the COVID-19 pandemic in Free State province, South Africa.
Sondlane H, Ogunbayo A, Donato C, Mogotsi M, Esona M, Hallbauer U
Virus Res. 2024; 347:199421.
PMID: 38942296
PMC: 11283024.
DOI: 10.1016/j.virusres.2024.199421.
Impact of Nirsevimab Immunization on Pediatric Hospitalization Rates: A Systematic Review and Meta-Analysis (2024).
Ricco M, Cascio A, Corrado S, Bottazzoli M, Marchesi F, Gili R
Vaccines (Basel). 2024; 12(6).
PMID: 38932369
PMC: 11209424.
DOI: 10.3390/vaccines12060640.
Effect of COVID-19 pandemic on influenza; observation of a tertiary level virology laboratory.
Jain A, Mahesh S, Prakash O, Khan D, Verma A, Rastogi Y
Virusdisease. 2024; 35(1):27-33.
PMID: 38817401
PMC: 11133273.
DOI: 10.1007/s13337-024-00860-3.
Epidemiology of Respiratory Syncytial Virus Hospitalizations in Poland: An Analysis from 2015 to 2023 Covering the Entire Polish Population of Children Aged under Five Years.
Mazela J, Jackowska T, Czech M, Helwich E, Martyn O, Aleksiejuk P
Viruses. 2024; 16(5).
PMID: 38793586
PMC: 11126078.
DOI: 10.3390/v16050704.
Risk Analysis of Respiratory Syncytial Virus Among Infants in the United States by Birth Month.
Gantenberg J, van Aalst R, Reddy Bhuma M, Limone B, Diakun D, Smith D
J Pediatric Infect Dis Soc. 2024; 13(6):317-327.
PMID: 38738450
PMC: 11212365.
DOI: 10.1093/jpids/piae042.
Epidemiology of respiratory syncytial virus in a large pediatric hospital in Central Italy and development of a forecasting model to predict the seasonal peak.
Cutrera R, Ciofi Degli Atti M, Dotta A, DAmore C, Rava L, Perno C
Ital J Pediatr. 2024; 50(1):65.
PMID: 38589886
PMC: 11003041.
DOI: 10.1186/s13052-024-01624-x.
Management and outcomes of bronchiolitis in Italy and Latin America: a multi-center, prospective, observational study.
Camporesi A, Yock-Corrales A, Gomez-Vargas J, Roland D, Gonzalez M, Barreiro S
Eur J Pediatr. 2024; 183(6):2733-2742.
PMID: 38554172
PMC: 11098874.
DOI: 10.1007/s00431-024-05530-6.
